Locations

Mercer Island, WA, USA · Seattle, WA, USA · University of Washington, Seattle, WA, USA

industry

Biotechnology

Size

11-50 employees

Stage

Series B

founded in

2019

Altpep develops early disease-modifying treatments and detection tools for amyloid diseases by targeting one of the earliest molecular triggers – toxic soluble oligomers. These oligomers are associated with many diseases, including neurodegenerative diseases and Type 2 diabetes. Decades of scientific research by the Daggett Research Group culminated in the discovery of a novel protein structure, alpha-sheet, the foundation of our innovative approach. Our lead program aims to identify Alzheimer’s disease long before symptoms occur and then neutralize the toxic soluble oligomers associated with the disease.

Something looks off?
Open jobs at AltPep
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.